z-logo
open-access-imgOpen Access
Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis
Author(s) -
C Jemal,
Jalal Haddad,
Dilara Begum,
Matthew P. Jackson
Publication year - 1995
Publication title -
journal of bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.652
H-Index - 246
eISSN - 1067-8832
pISSN - 0021-9193
DOI - 10.1128/jb.177.11.3128-3132.1995
Subject(s) - pentamer , biology , mutagenesis , protein subunit , biochemistry , aspartic acid , amino acid , diphtheria toxin , transmembrane domain , shiga toxin , arginine , random hexamer , site directed mutagenesis , peptide sequence , microbiology and biotechnology , toxin , mutant , escherichia coli , gene
Shiga toxin (STX), a bacterial toxin produced by Shigella dysenteriae type 1, is a hexamer composed of five receptor-binding B subunits which encircle an alpha-helix at the carboxyl terminus of the enzymatic A polypeptide. Hybrid toxins constructed by fusing the A polypeptide sequences of STX and Shiga-like toxin type II were used to confirm that the carboxyl terminus of the A subunits governs association with the B pentamers. The alpha-helix of the 293-amino-acid STX A subunit contains nine residues (serine 279 to methionine 287) which penetrate the nonpolar pore of the B-subunit pentamer. Site-directed mutagenesis was used to establish the involvement of two residues bordering this alpha-helix, aspartic acid 278 and arginine 288, in coupling the C terminus of StxA to the B pentamer. Amino acid substitutions at StxB residues arginine 33 and tryptophan 34, which are on the membrane-contacting surface of the pentamer, reduced cytotoxicity without affecting holotoxin formation. Although these B-subunit mutations did not involve receptor-binding residues, they may have induced an electrostatic repulsion between the holotoxin and the mammalian cell membrane or disrupted cytoplasmic translocation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here